{"id":"https://openalex.org/W2805541979","doi":null,"title":"Promising activity of farnesyltransferase inhibitors across seven different sarcoma subtypes","display_name":"Promising activity of farnesyltransferase inhibitors across seven different sarcoma subtypes","publication_year":2006,"publication_date":"2006-04-15","ids":{"openalex":"https://openalex.org/W2805541979","mag":"2805541979"},"language":"en","primary_location":{"id":"mag:2805541979","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/66/8_Supplement/894.4","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031037291","display_name":"William D. Tap","orcid":"https://orcid.org/0000-0001-7779-2796","observed_orcids":["https://orcid.org/0000-0001-7779-2796"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William D. Tap","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":"https://orcid.org/0000-0001-7779-2796","affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070688871","display_name":"Jiang Chen","orcid":"https://orcid.org/0000-0002-0010-0402","observed_orcids":["https://orcid.org/0000-0002-0010-0402"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiang Chen","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":"https://orcid.org/0000-0002-0010-0402","affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077449490","display_name":"Fritz C. Eilber","orcid":"https://orcid.org/0000-0003-3336-9333","observed_orcids":["https://orcid.org/0000-0003-3336-9333"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fritz C. Eilber","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022515246","display_name":"Juran Kato\u2010Stankiewicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juran Kato\u2010Stankiewicz","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069276944","display_name":"Jed P. Needle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jed P. Needle","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009971985","display_name":"Amrita J. Desai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amrita J. Desai","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. Glaspy","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":"https://orcid.org/0000-0002-1800-9076","affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021949734","display_name":"Fuyuhiko Tamanoi","orcid":"https://orcid.org/0000-0002-4220-6408","observed_orcids":["https://orcid.org/0000-0002-4220-6408"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fuyuhiko Tamanoi","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":"https://orcid.org/0000-0002-4220-6408","affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.44916964,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"66","issue":null,"first_page":"894","last_page":"895"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9199000000953674,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9199000000953674,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.9430000185966492},{"id":"https://openalex.org/keywords/synovial-sarcoma","display_name":"synovial sarcoma","score":1.0},{"id":"https://openalex.org/keywords/uterine-sarcoma","display_name":"uterine sarcoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/ribosomal-protein-s6-phosphorylation","display_name":"S6 phosphorylation","score":0.8519999980926514},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.8240000009536743},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7080000042915344},{"id":"https://openalex.org/keywords/sarcoma-cell-lines","display_name":"sarcoma cell lines","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C2778396349","wikidata":"https://www.wikidata.org/wiki/Q410994","display_name":"Farnesyltransferase","level":4,"score":0.8048610687255859},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.6981700658798218},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6598199009895325},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5230263471603394},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5102431774139404},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5010313987731934},{"id":"https://openalex.org/C2777827897","wikidata":"https://www.wikidata.org/wiki/Q5436005","display_name":"Farnesyltransferase inhibitor","level":5,"score":0.49922633171081543},{"id":"https://openalex.org/C2776910622","wikidata":"https://www.wikidata.org/wiki/Q2619315","display_name":"Synovial sarcoma","level":3,"score":0.45911094546318054},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.458175390958786},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3824195861816406},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.35493776202201843},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3517147898674011},{"id":"https://openalex.org/C57790582","wikidata":"https://www.wikidata.org/wiki/Q901141","display_name":"Prenylation","level":3,"score":0.34903401136398315},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3245342969894409},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2796770930290222},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.13053631782531738},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.08566951751708984},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08103573322296143}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2805541979","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/66/8_Supplement/894.4","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":null,"raw_source_name":"Cancer Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8399999737739563,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2155267526","https://openalex.org/W2135372494","https://openalex.org/W2624850365","https://openalex.org/W13524344","https://openalex.org/W3183465146","https://openalex.org/W127788025","https://openalex.org/W2886786384","https://openalex.org/W1499637762","https://openalex.org/W2167003037","https://openalex.org/W2145047343","https://openalex.org/W2127905742","https://openalex.org/W2345786810","https://openalex.org/W2003752694","https://openalex.org/W2971650649","https://openalex.org/W1606702555","https://openalex.org/W2113365503","https://openalex.org/W2740732030","https://openalex.org/W101598144","https://openalex.org/W2061497525","https://openalex.org/W2406263010"],"abstract_inverted_index":{"3805":[0],"Sarcomas":[3,37],"are":[4,38,281,287],"a":[5,25,29,53,221,234],"heterogeneous":[6],"group":[7],"of":[8,21,33,44,51,73,120,146,167,192,204,213,230,237,241,247,258,260,272],"mesenchymal":[9],"malignancies":[10],"whose":[11,150],"benefit":[12],"from":[13],"traditional":[14],"chemotherapy":[15],"has":[16],"been":[17],"maximized.":[18],"A":[19],"diagnosis":[20],"sarcoma":[22,70,78,85,88,262],"still":[23],"portends":[24],"poor":[26],"prognosis":[27],"with":[28,48,196,227,275],"disease":[30],"specific":[31,155],"mortality":[32],"up":[34],"to":[35,94,125,140,154,173,209,224],"50%.":[36],"fertile":[39],"ground":[40],"for":[41,91,176],"the":[42,49,118,147,189,193,228,245,256,268],"application":[43],"novel,":[45],"targeted":[46],"therapies":[47],"hope":[50],"identifying":[52],"treatment":[54],"effective":[55],"across":[56],"histologic":[57],"subtypes.":[58],"We":[59],"report":[60],"that":[61,225,252],"farnesyltransferase":[62],"inhibitors":[63],"(FTIs)":[64],"demonstrate":[65],"in":[66,117,132,138,162,188,201,216,220],"vitro":[67],"activity":[68],"against":[69],"cell":[71,110,181,194,218,263],"lines":[72,219,264],"variable":[74],"histologies.":[75],"Seven":[76],"different":[77],"subtypes,":[79],"including":[80],"osteosarcoma,":[81],"synovial":[82],"sarcoma,":[83],"uterine":[84],"and":[86,99,112,159,165,289],"Ewing\u2019s":[87],"were":[89,116,152],"examined":[90],"their":[92,163,177],"sensitivity":[93],"two":[95],"FTI":[96,210],"compounds,":[97],"BMS214662":[98,158],"BMS225975.":[100],"Both":[101],"compounds":[102],"demonstrated":[103],"exquisite":[104],"growth":[105,131,257],"inhibition":[106,212],"as":[107,279],"detected":[108],"by":[109,265],"count":[111],"MTT":[113],"assays.":[114],"IC50\u2019s":[115],"range":[119],"125-400":[121],"nanomolars,":[122],"concentrations":[123],"known":[124],"inhibit":[126,255],"farnesylation.":[127],"FTIs":[128,253,274],"inhibited":[129],"cellular":[130],"every":[133],"histology":[134],"tested.":[135],"This":[136],"is":[137,233],"contrast":[139],"other":[141,276],"signal":[142],"transduction":[143],"inhibitors,":[144],"i.e.":[145],"MAPK":[148],"pathway,":[149],"effects":[151],"limited":[153],"pathologies":[156],"alone.":[157],"BMS225975":[160],"differ":[161],"potency":[164],"mechanism":[166],"action,":[168],"providing":[169],"an":[170,186],"accurate":[171],"tool":[172],"evaluate":[174],"reasons":[175],"efficacy.":[178],"In":[179],"most":[180],"lines,":[182],"FACS":[183],"analysis":[184],"showed":[185],"accumulation":[187],"G1":[190],"phase":[191],"cycle":[195],"little":[197],"or":[198],"no":[199],"increase":[200],"apoptosis.":[202],"Investigations":[203],"signaling":[205],"properties":[206],"after":[207],"exposure":[208],"revealed":[211],"S6":[214,232],"phosphorylation":[215],"some":[217,259],"fashion":[222],"similar":[223],"seen":[226],"use":[229],"rapamycin.":[231],"downstream":[235],"effector":[236],"mTOR.":[238],"The":[239],"activation":[240],"mTOR/S6K":[242],"relies":[243],"on":[244],"farnesylation":[246],"Rheb.":[248],"These":[249,285],"results":[250,286],"suggest":[251],"may":[254],"our":[261],"down":[266],"regulating":[267],"TSC/Rheb/mTOR":[269],"pathway.":[270],"Effects":[271],"combining":[273],"reagents":[277],"such":[278],"taxanes":[280],"currently":[282],"being":[283],"investigated.":[284],"forthcoming":[288],"will":[290],"be":[291],"discussed.":[292]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2025-10-10T00:00:00"}